Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHS.L Regulatory News (GHS)

  • There is currently no data for GHS

Net Asset Value Update

24 Nov 2021 13:13

RNS Number : 4846T
Gresham House Strategic PLC
24 November 2021
 

Gresham House Strategic plc

("GHS" or the "Company")

Net Asset Value Update

The Board of GHS announces that it has today been advised by its recently appointed investment manager, Harwood Capital LLP, that the realisation of the Augean proceeds, which gave rise to a gain of £18.8m, together with other recent profitable sales will give rise to a tax liability which was not provided for in the NAV calculations and that as a result, its weekly net asset values have been incorrectly stated since 30 July 2021, the date on which an offer for Augean was formally announced.

The net impact of the overstatement was approximately £1.3 million as at 19 November 2021 (approximately 2% of NAV), the date of the last NAV released by GHS. The amount is made up of a tax provision of approximately £1.6 million less an overpayment of management and performance fees to Gresham House Asset Management (GHS's former investment manager) of approximately £0.3m (inclusive of VAT), which the Board now intends to reclaim.

Whilst the Company has significant brought forward capital losses, changes to the tax legislation which became effective on 1 April 2020 limit the use of capital losses against realised gains to £5 million per year. Thereafter, 50 per. cent of realised gains are subject to corporation tax. The net effect is that realised gains over £5 million per annum are currently taxed at 9.5 per cent. and not zero as was previously the case.

Further, the Board has been advised that if the entire GHS portfolio was liquidated today at current market prices which follows the announcement of the proposed takeover of Universe Group yesterday and which will, if concluded give rise to a gain of £3 million, there would be an additional corporation tax liability of approximately £1.3 million (approximately 2% of NAV).

The Board is arranging for all the weekly NAV calculations to be recalculated since 30 July 2021 and they will be released to the market when this exercise is concluded.

A further announcement will be made in due course.

 

Enquiries:

Gresham House Strategic

Ken Lever, Senior Independent Director

+44 (0) 20 7220 0500

 

Harwood Capital LLP

Christopher Mills

+ 44 (0) 20 7640 3200

finnCap (Nominated Adviser and Joint Broker to GHS)

William Marle / Ed Frisby / Mark Whitfeld / Pauline Tribe

 

+44 (0) 20 7220 0500

Panmure Gordon (UK) Limited (Joint Broker to GHS)

Sapna Shah / Alex Collins

 

+44 (0) 20 7886 2500

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVDKQBDNBDDBDB
Date   Source Headline
6th Mar 20172:00 pmRNSNAV Update
1st Mar 20171:47 pmRNSMonthly NAV Update
27th Feb 20173:25 pmRNSNAV Update
20th Feb 20172:45 pmRNSNAV Update
13th Feb 201711:48 amRNSNAV Update
6th Feb 201711:04 amRNSNAV Update
1st Feb 20172:45 pmRNSMonthly NAV Update
30th Jan 20173:35 pmRNSNAV update
23rd Jan 20171:30 pmRNSNAV Update
18th Jan 20174:35 pmRNSDirector/PDMR Shareholding
16th Jan 20173:30 pmRNSNAV Update
10th Jan 20171:19 pmRNSHolding(s) in Company
9th Jan 20172:21 pmRNSNAV Update
3rd Jan 201712:46 pmRNSMonthly NAV Update
28th Dec 201610:29 amRNSNAV Update
19th Dec 20162:49 pmRNSNAV Update
12th Dec 20161:54 pmRNSNAV Update
5th Dec 20162:51 pmRNSNAV Update
1st Dec 20162:24 pmRNSMonthly NAV Update
28th Nov 20163:34 pmRNSNAV Update
25th Nov 20167:00 amRNSInterim Results
21st Nov 20161:00 pmRNSNAV Update
14th Nov 20162:47 pmRNSNAV Update
7th Nov 201612:12 pmRNSNAV Update
1st Nov 201612:40 pmRNSMonthly NAV Update
31st Oct 20163:49 pmRNSNAV Update
24th Oct 20162:04 pmRNSNAV Update
17th Oct 201612:23 pmRNSNAV Update
10th Oct 20162:24 pmRNSNAV Update
7th Oct 201611:03 amRNSDirector/PDMR Shareholding
3rd Oct 20161:55 pmRNSNAV Update
26th Sep 201612:00 pmRNSNAV Update
19th Sep 201612:50 pmRNSNAV Update
16th Sep 20164:15 pmRNSHolding(s) in Company
12th Sep 201612:05 pmRNSNAV Update
5th Sep 20162:31 pmRNSNAV Update
1st Sep 20162:15 pmRNSNAV Update
30th Aug 201612:40 pmRNSNAV Update
25th Aug 20167:00 amRNSDirector's Dealing
22nd Aug 201611:56 amRNSNAV Update
18th Aug 201612:02 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
18th Aug 201612:02 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
16th Aug 20167:00 amRNSStrategic Co-Investment Agreement
15th Aug 201611:25 amRNSNAV Update
12th Aug 201612:12 pmRNSHolding(s) in Company
8th Aug 20164:19 pmRNSNAV Update
1st Aug 20163:25 pmRNSNAV Update
26th Jul 20167:00 amRNSHolding(s) in Company
25th Jul 20163:08 pmRNSNAV Update
25th Jul 20162:54 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.